Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALLK
3101
DELISTED
Allakos
ALLK
| $2.05M | ﹤0.01% |
1,629,821
+39,708
| +2% | +$61.7K |
|
|
VRN
3102
DELISTED
Veren
VRN
| $2.04M | ﹤0.01% |
248,260
-209,630
| -46% | -$1.47M |
|
|
USAP
3103
DELISTED
Universal Stainless & Alloy
USAP
| $2.03M | ﹤0.01% |
90,631
+2,681
| +3% | +$54.2K |
|
|
IVAC
3104
DELISTED
Intevac Inc
IVAC
| $2.03M | ﹤0.01% |
528,627
-824
| -0.2% | -$3.3K |
|
3105
InnovAge Holding
INNV
$1.52B
| $2.02M | ﹤0.01% |
454,609
+2,490
| +0.6% | +$13.1K |
|
3106
Caledonia Mining Corp
CMCL
$420M
| $2.02M | ﹤0.01% |
182,203
+6,527
| +4% | +$69.9K |
|
3107
INmune Bio
INMB
$57.7M
| $2.01M | ﹤0.01% |
170,802
+762
| +0.4% | +$9.21K |
|
3108
Expensify
EXFY
$245M
| $2M | ﹤0.01% |
1,086,335
-2,189
| -0.2% | -$4.16K |
|
|
SBT
3109
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $2M | ﹤0.01% |
387,055
+17,020
| +5% | +$88.6K |
|
3110
Vor Biopharma
VOR
$1.28B
| $1.99M | ﹤0.01% |
42,060
+2,357
| +6% | +$103K |
|
3111
ReposiTrak
TRAK
$159M
| $1.99M | ﹤0.01% |
125,300
-341
| -0.3% | -$4.48K |
|
|
HIVE
3112
HIVE Digital Technologies
HIVE
$777M
| $1.98M | ﹤0.01% |
588,029
+121,255
| +26% | +$432K |
|
3113
TELA Bio
TELA
$38.9M
| $1.98M | ﹤0.01% |
349,723
+3,061
| +0.9% | +$20.2K |
|
|
LENZ
3114
LENZ Therapeutics
LENZ
$168M
| $1.97M | ﹤0.01% |
88,218
+8,910
| +11% | +$185K |
|
3115
AirSculpt Technologies
AIRS
$353M
| $1.96M | ﹤0.01% |
319,737
+18,515
| +6% | +$126K |
|
|
ASRT
3116
DELISTED
Assertio
ASRT
| $1.96M | ﹤0.01% |
136,422
+2,929
| +2% | +$39.9K |
|
3117
Kopin
KOPN
$791M
| $1.95M | ﹤0.01% |
1,085,567
+24,341
| +2% | +$54.1K |
|
|
NAGE
3118
Niagen Bioscience
NAGE
$247M
| $1.95M | ﹤0.01% |
561,059
+57,116
| +11% | +$106K |
|
3119
Southern California Bancorp
BCAL
$682M
| $1.95M | ﹤0.01% |
130,738
+4,498
| +4% | +$71.1K |
|
3120
Pioneer Bancorp
PBFS
$434M
| $1.95M | ﹤0.01% |
198,431
+9,007
| +5% | +$86.1K |
|
3121
Rigetti Computing
RGTI
$5.99B
| $1.95M | ﹤0.01% |
1,271,536
+108,924
| +9% | +$157K |
|
3122
Aclaris Therapeutics
ACRS
$869M
| $1.94M | ﹤0.01% |
1,565,054
+171,506
| +12% | +$205K |
|
3123
Black Diamond Therapeutics
BDTX
$112M
| $1.94M | ﹤0.01% |
382,613
+32,167
| +9% | +$130K |
|
|
FFNW
3124
DELISTED
First Financial Northwest, Inc
FFNW
| $1.93M | ﹤0.01% |
93,949
+4,258
| +5% | +$84.8K |
|
3125
Alto Ingredients
ALTO
$340M
| $1.93M | ﹤0.01% |
885,622
+17,650
| +2% | +$37.2K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.